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Abstract
Background: Self-collection of anorectal swab specimens could greatly facilitate the completion
of prerequisite studies and future implementation of anal cancer screening among men who have
sex with men (MSM). We therefore compared self- versus clinician- collection procedures with
respect to specimen adequacy for cytological evaluation, concordance of paired cytological results,
and concordance of cytological with biopsy results.
Methods: Paired self- and clinician- collected anorectal Dacron® swabs for liquid-based (Thin
Prep®) cytological evaluation were collected in random sequence from a mostly HIV-1 seronegative
cohort of young MSM in Vancouver. Slides were reviewed by one cytopathologist. Presence of any
cytological abnormality (atypical squamous cells of uncertain significance, ASCUS, or above)
prompted referral for high-resolution anoscopy and possible biopsy.
Results:  Among 222 patient-clinician specimen pairs, most were adequate for cytological
evaluation, though self-collected specimens were less likely to be so (83% versus 92%, McNemar's
test p < 0.001). Cytological abnormalities, noted in 47 (21%) of self-collected and 47 (21%) of
clinician-collected specimens (with fair agreement, kappa = 0.414) included, respectively: ASCUS
(5%, 5%), and low-grade (13%, 13%) and high-grade (3%, 3%) squamous intraepithelial lesions.
Among 12 men with biopsy-confirmed high-grade neoplasia, most had abnormal cytological results
(including 6 patient and 9 clinician swabs) but few (2 patient and 1 clinician swab) were high-grade.
Conclusion: Self-collection of anorectal swab specimens for cytologic screening in research and
possibly clinical settings appears feasible, particularly if specimen adequacy can be further improved.
The severity of biopsy-confirmed anorectal disease is seriously underestimated by cytological
screening, regardless of collector.
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Introduction
Anal cancer in the general population is rare, with an inci-
dence of only 0.8 cases per 100,000 per year. However, the
incidence of this malignancy has increased during the past
three decades [1-3]. Risk of anal cancer is greatly elevated
among HIV-1 seronegative and HIV-1 seropositive men
who have sex with men (MSM), in whom 35-fold and 70-
fold relative risks, respectively, have been reported [4-6].
Since publication of these risk estimates, two very recent
studies suggest that incidence rates among HIV-1 seropos-
itive MSM may have further doubled, owing to increased
survival since 1996 among men receiving potent antiret-
roviral treatment [7,8].
Among MSM, the prevalence of human papillomavirus
(HPV) infection and of precursor anal squamous intraep-
ithelial lesions does not appear to decrease with age
[9,10]. Early detection and ablation of precursor lesions in
the anal canal might reduce mortality from anal cancer,
just as early detection by Pap smear and treatment has
reduced mortality from cervical cancer [11]. Liquid-based
anal cytological specimens perform comparably to con-
ventional anorectal smears [12] and though modest in
sensitivity, both may be adequate for screening purposes
[12-17].
However, estimates of the cost-effectiveness of screening
are strongly sensitive to model assumptions about the rate
with which high-grade squamous intraepithelial lesions
progress to invasive anal cancer, a rate that is unknown,
and to the effectiveness of treatment in preventing this
progression [18,19]. Current treatment of HIV-1 seroneg-
ative MSM appears to be effective in clearing abnormal
squamous cells from the anorectal canal; in contrast, an
extraordinary rate of anogenital lesion persistence and
recurrence among HIV-1 seropositive men and women
represents a serious impediment to implementing routine
screening at this time [20-22].
Development of evidence-based policies regarding rou-
tine screening of MSM for anal cancer therefore requires
collection of additional natural history, treatment and
acceptability data from large, diverse samples of men
[23,24]. These studies will be easier and less costly to com-
plete if anorectal swab specimens for cytological evalua-
tion can be self-collected. Future screening coverage is also
likely to be greater if self-sampling is possible. Only one
evaluation of such self-collection has been published and
that study included only 20 HIV-1 seronegative MSM
[25]. We therefore compared self- versus clinician-collec-
tion procedures in a large cohort of mostly HIV-1 seroneg-
ative MSM; our endpoints included specimen adequacy
for cytological evaluation, concordance of cytological
results, and relative concordance of cytological and his-
topathological results.
Methods
Study population
We conducted a cross-sectional study within the Vanguard
Project, a prospective cohort of HIV incidence and risk
behaviors among young HIV-1 seronegative MSM aged 18
to 30 in Vancouver [26,27]. The study protocol was
approved by the University of British Columbia Clinical
Ethics Research Board. Each participant provided written
informed consent and received a $20 honorarium. Study
visits included completion of a brief self-administered
questionnaire.
Specimen collection
Each participant provided at the same study visit two
anorectal swab specimens: one self-collected and one col-
lected by the study clinician. Because we were unsure
whether the second swab would yield fewer cells and be
less adequate for cytological evaluation, we randomly
assigned each individual the order in which their paired
swabs (self versus clinician) were to be collected. The
order was designated on a card placed in a sealed envelope
and included in previously prepared specimen collection
kits. These kits included two sterile Dacron® polyester
tipped swabs, two bottles of PreservCyt® solution (Cytyc
Corporation, Boxborough Mass.), a biohazard transport
bag, and illustrated step-by-step instructions for self-col-
lection [28].
Swabs were inserted approximately 4–6 cm beyond the
anal verge, then used to gently wipe the anal canal wall,
then rotated 360° during slow removal. The swab was
then placed in PreservCyt®, the plastic shaft was snapped,
and the container was capped tightly. Self-and clinician-
collected specimens were labeled with unique identifica-
tion numbers, placed in separate transport bags, and sent
immediately for cytological examination.
Cytological examination
One cytopathologist (DvN), reviewed all slides without
knowledge of their having been self- or clinician- col-
lected. Samples were considered adequate for cytological
examination regardless of the presence of glandular cells,
as long as they contained 5,000 well-preserved squamous
cells, at least 75% of which were not obscured by covering
inflammation, blood or fecal material. Adequate speci-
mens were evaluated using 2001 Bethesda criteria and
diagnosed as moderate to high-grade squamous intraepi-
thelial lesion (high-grade, or HSIL), low-grade squamous
intraepithelial lesion (low grade, or LSIL), atypical squa-
mous cells of undetermined significance (ASCUS), or neg-
ative for atypical or malignant cells ("normal"). Men with
any cytological abnormality (including ASCUS) were
referred promptly for anoscopy and possible biopsy.CytoJournal 2006, 3:4 http://www.cytojournal.com/content/3/1/4
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Statistical analysis
Group comparisons were performed using two-sided Chi-
square, Fisher's Exact, and Wilcoxon rank sum tests (alpha
= 0.05). Pair-wise agreement with respect to binary end-
points (specimen adequacy, detection of any cytological
abnormality including ASCUS) were performed using
McNemar's Chi-square and kappa statistics computed
with SAS v.8.2 for PC (SAS Institute, Cary, NC).
Results
Between July 2003 and April 2004, 222 men provided
paired anorectal swab specimens for cytological examina-
tion. The median age of study participants was 31.5 years
and approximately half had completed college (Table 1).
Most men were HIV-1 seronegative; the 28 HIV-1 serocon-
verters had been infected for a median of 2.0 years. No sig-
nificant differences among measured demographic
characteristics were observed between men randomly
assigned to initial self-collection versus clinician collec-
tion (Table 1).
Cytological adequacy of specimens
Specimens collected second were not cytologically less
adequate than those collected first, despite significant
pair-wise disagreement for this endpoint (McNemar's test
p = 0.040, kappa = 0.288). Among the 222 participants,
44 had at least one anorectal swab specimen inadequate
for cytological evaluation: in 10 men (4.5%) both speci-
mens were inadequate, in 23 men (10.4%) only the first
swab was inadequate, and in 11 men (5.0%) only the sec-
ond swab was inadequate (Table 2).
Similarly, specimens collected second were not less likely
to have a cytological abnormality (ASCUS, LSIL or HSIL)
detected, compared to those collected first (McNemar's
test p = 0.564, kappa = 0.353). Cytological abnormalities
Table 2: Paired cytology results, by order of anorectal swab collection (n = 222).
Second Swab 
Result
First Swab Result
Normal ASCUS LSIL HSIL Inadequate Total
Normal 114 4 12 5 21 156 (70)
A S C U S 1 0 0121 1 4  ( 6 )
LSIL 10 3 13 0 1 27 (12)
H S I L 00220 4  ( 2 )
I n a d e q u a t e 6320 1 0 2 1  ( 9 )
Total 140 (63) 10 (5) 30 (14) 9 (4) 33 (15) 222 (100)
Table 1: Characteristics of study participants, overall and by randomly assigned order of swab collection.
Clinician Collected First 
Specimen (n = 115)
Client Collected First 
Specimen (n = 107)
Total Study Population 
(n = 222)
Age, median years (IQR) 31.0 (28, 35) 32.0 (28, 35) 31.5 (28, 35)
College graduate, n (%)
Yes 50 (45) 51 (50) 101 (47)
No 61 (55) 51 (50) 112 (53)
Full-time employment, n (%)
Yes 56(50) 62 (61) 118 (55)
No 57 (50) 41 (39) 98 (45)
Stable housinga, n (%)
Yes 99 (86) 93 (88) 192 (87)
No 16 (14) 13 (12) 29 (13)
Sex trade involvementa, n (%)
Yes 13 (12) 11 (11) 24 (11)
No 100 (89) 93 (89) 193 (89)
Injection drug usea, n (%)
Yes 12 (11) 7 (7) 19 (9)
No 101 (89) 98 (93) 199 (91)
HIV-1 seropositive, n (%)
Yes 18 (16) 10 (9) 28 (13)
No 97 (84) 97 (91) 194 (87)
a in previous 12 monthsCytoJournal 2006, 3:4 http://www.cytojournal.com/content/3/1/4
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were detected in a total of 71 men: both specimens were
abnormal in 23 men (10.4%), the first swab alone was
abnormal in 26 men (11.7%), and the second swab alone
was abnormal in 22 men (9.9%) (Table 2).
Overall, the number of cytologically inadequate speci-
mens was low among self-collected swabs (n = 37, 16.7%)
and among clinician-collected swabs (n = 17, 7.7%).
However, we found self-collected specimens were less fre-
quently adequate, compared to clinician-collected speci-
mens (McNemar's test p<0.001, kappa = 0.297). In
addition to 10 men (4.5%) in whom both swabs were
inadequate, 27 men (12.2%) had an inadequate self-col-
lected swab specimen, and 7 men (3.2%) had an inade-
quate clinician-collected swab specimen (Table 3).
We did not find that specimens self-collected by men
already experienced in the procedure as performed by a
clinician (i.e., self-collected second swabs) were more ade-
quate that those collected by men wholly naïve to the pro-
cedure (i.e., self-collected first swabs) [21 (19.6%) of 107
versus 16 (13.9%) of 115 respectively, Chi-square p =
0.253]. Further, in the vast majority of men having inade-
quate self- [21 (78%) of 27] or clinician-collected [6
(86%) of 7] specimens, the cytological diagnoses availa-
ble from the alternate swab specimen were normal [21
(7.8%) of 27 and 6 (86%) of 7, respectively]; none were
high-grade (Table 3).
Detection of cytological abnormalities
The overall numbers of self- and clinician-collected swabs
with a cytological abnormality [47 (21%) of 222 each]
were identical. Most cytologically adequate specimens
collected by participants [138 (74.6%) of 185] and the cli-
nician [158 (77.1%)] were normal; these proportions
were not significantly different (Chi-square p = 0.568).
Although based on a small number of seroconverters in
our sample, men with and without HIV-1 infection were
not significantly different with respect to detection of a
cytological abnormality (Chi-square p = 0.143).
We did not observe significant pair-wise disagreement
between self-and clinician-collected swabs with regard to
detection of a cytological abnormality (McNemar's test p
= 0.435, kappa 0.414): both specimens were abnormal in
23 men (12.9%), the self-collected swab alone was abnor-
mal in 23 men (12.9%) and the clinician-collected swab
alone was abnormal in 18 men (13.6%). Despite this fair
agreement with regard to the presence of any cytological
abnormality, the specific diagnoses obtained in paired
self- and clinician-collected specimens differed in many
instances (Table 3).
Correspondence of cytological with histopathological 
results
Among the 71 men in whom any cytological abnormality
was noted, 64 (90.1%) returned for follow-up anoscopic
examination and 41 underwent biopsies of visible inter-
nal lesions. Histopathological findings in the latter
included 11 normal diagnoses, 18 diagnoses of AIN 1,
and 12 diagnoses of AIN 2/3 (Table 4).
High-grade anal intraepithelial neoplasia (AIN 2 or AIN
3) was confirmed by biopsy in a total of 12 men. Of note,
among these 12 men, few had moderate or high-grade
diagnoses (HSIL) in their self-collected (2 of 9 adequate
swabs) or clinician-collected (1 of 11 adequate swabs)
specimens (Table 4). However, most cytological results
for these 12 men (including 6 patient and 9 clinician)
were abnormal, using ASCUS or above as our criterion.
Discussion
In our community-recruited cohort of young, highly edu-
cated, mostly HIV-1 seronegative MSM naive to anorectal
cytologic sampling, we found the vast majority of self-col-
lected swab specimens were adequate for examination,
though self-collected specimens were less likely to be so.
Further, we did not observe any material difference in the
overall distribution of cytological diagnoses obtained
using clinician- versus self-collected specimens. However,
we noted only fair within-pair agreement with respect to
both the presence of any abnormality and the specific
Table 3: Paired cytology results, by collector of anorectal swab specimen (n= 222).
Clinician-
Collected 
Specimen
Self-Collected Specimen
Normal ASCUS LSIL HSIL Inadequate Total n (%)
Normal 114 7 13 3 21 158 (71)
A S C U S 70113 1 2  ( 5 )
L S I L 93 1 3 13 2 9  ( 1 3 )
H S I L 21120 6  ( 3 )
I n a d e q u a t e 6100 1 0 1 7  ( 8 )
Total n (%) 138 (62) 12 (5) 28 (13) 7 (3) 37 (17) 222 (100)CytoJournal 2006, 3:4 http://www.cytojournal.com/content/3/1/4
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cytological diagnoses in self- and clinician-collected spec-
imens. This latter result was expected, as individuals'
anorectal specimens collected over short periods of time
display similarly poor concordance. For example, the
detection of any abnormality in serial specimens collected
over time from MSM in another study yielded a correla-
tion similar to our own (kappa = 0.33) [29]. This limited
concordance probably reflects sampling variability and
only moderate levels of intra-and inter-observer agree-
ment in the reading of anorectal cytological specimens
[30].
We observed considerable discordance between individu-
als' cytological and histopathological diagnoses. Impor-
tantly, anorectal cytology underestimated the severity of
neoplasia in nearly every case of biopsy-confirmed high-
grade neoplasia, regardless of who collected the swab
specimen. As well, we found that a greater number of cli-
nician-collected (n = 9) than self-collected (n = 6) speci-
mens obtained from these 12 men were cytologically
abnormal (ASCUS or above) and thus would have
prompted referral for follow-up anoscopy and possible
biopsy.
Our results are consistent with the only previous study to
evaluate cytological specimens self-collected by MSM.
Cranston et al reported a nearly identical adequacy (85%)
among 20 cytological specimens self-collected by HIV-1
seronegative MSM [25]. In that study, cytological abnor-
malities were noted in only 4 of 10 men with biopsy-con-
firmed moderate or high-grade disease. Similarly, we
found that only 3 of 12 men with biopsy-confirmed high-
grade disease had a corresponding cytological diagnosis;
most had cytological diagnoses of low-grade dysplasia or
ASCUS. In this regard, our results support the recommen-
dation by others that detection of any cytological abnor-
mality (including ASCUS) in anorectal specimens
warrants referral of MSM for high-resolution anoscopy
[13,16].
The distribution of cytological and histological diagnoses
in both self-collected and clinician-collected specimens in
our study is similar to that reported from previous studies
that included HIV-1 seronegative MSM [5,25,31,32].
Using any cytological abnormality (including ASCUS) as
our criterion for referral, we found one fifth of HIV-1
seronegative men require follow-up anoscopy on the basis
of a single screen and that about one third require such
Table 4: Comparison of 64 paired self- and clinician-collected anorectal cytologic results in relation to results from anoscopy and 
possible biopsy.
Biopsy Result
Biopsy Not Performed Normal
Patient Cytology Result Patient Cytology Result
Inadequat
e
Normal ASCUS LSIL HSIL Inadequat
e
Normal ASCUS LSIL HSIL
Clinician 
Cytology 
Result
Inadequat
e
21 2
N o r m a l 2221 1 1
ASCUS 1 4 1
L S I L 213 13
HSIL 2 2
AIN 1 AIN 2/3
Patient Cytology Result Patient Cytology Result
Inadequat
e
Normal ASCUS LSIL HSIL Inadequat
e
Normal ASCUS LSIL HSIL
Clinician 
Cytology 
Result
Inadequat
e
1
N o r m a l 224 1 1
ASCUS 1 1 1
L S I L 1214 2 31
HSIL 1 1CytoJournal 2006, 3:4 http://www.cytojournal.com/content/3/1/4
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referral when two specimens are collected; clearly, repeat
testing will improve detection of anorectal disease. None-
theless, two concerns in particular should give pause to
those who would at present advocate routine cytological
screening of MSM, including those who are HIV-1 serop-
ositive: (1) the lack of effective treatments and (2) the
need to revisit assumptions underlying claims that screen-
ing is cost-effective.
The present study has unique strengths and represents the
first truly controlled evaluation of self-screening among
MSM. Unlike the only other self-collection study involv-
ing MSM [25], both of our cytological specimens were liq-
uid-based and collected at the same study visit; the order
of swab collection was random; we provided detailed,
illustrated instructions for the self-collection procedure
[28]; and cytological evaluation by one cytopathologist
was performed blind to the source of the specimen. Fur-
ther, rates of follow-up anoscopy and biopsy were very
high. Finally, the MSM we studied were wholly inexperi-
enced with regard to collection of anorectal swabs for
cytological evaluation. As with almost all studies of MSM,
ours was not a population-based sample and the repre-
sentativeness of our study participants is unclear; at mini-
mum, our results should not be generalized to HIV-1
seropositive women and men.
Results from the present study have important short- and
long-term implications. Their immediate significance per-
tains to research. We have demonstrated that self-collec-
tion is possible and only marginally worse than clinician-
collected cytology. However, our finding that more men
with biopsy-proven high-grade disease were detected dur-
ing clinician- than during self-screening underscores the
need for more work in this area.
If self-collection performs suitably in follow-up studies
that aim to improve specimen adequacy, data needed to
inform decisions regarding introduction of routine
screening might be generated more rapidly and at reduced
cost in large samples of MSM. At present, studies are
needed to measure the prevalence of anal squamous
intraepithelial lesions in more representative samples of
MSM, the rate of spontaneous regression of lesions, the
efficacy and effectiveness of treatment, and the acceptabil-
ity of screening in diverse sub-populations of MSM. Addi-
tional studies are also required to correct for verification
bias in estimating the sensitivity, specificity and predictive
values of cytological screening; these studies require biop-
sies from large numbers of cytologically normal MSM
[33,34].
In summary, we found the vast majority of self-collected
anorectal swab specimens from MSM were adequate for
cytological evaluation. We also found similar frequencies
of abnormalities in self- and clinician-collected speci-
mens. Despite the generally comparable performance of
clinician- and self-collected anorectal specimens, an
important goal is the improvement of cytological ade-
quacy in the latter. Based on the results of our study, this
is unlikely to be achieved by simply having MSM undergo
their first screen by a trained clinician; rather, it will prob-
ably be necessary that men use a larger Dacron® swab, or
self-collect a second swab for placement into the same
PreservCyt® container. Studies also need to demonstrate
concordance of type-specific HPV and its correlates in self-
and clinician-collected specimens; toward this end, initial
results using a sub-sample of specimens collected during
this study are very promising [35].
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